Chemical Oxygen Demand (COD) Assessment for Pharmaceutical Wastewater: Methods, Standards and Applic

Chemical Oxygen Demand (COD) assessment is the cornerstone of pharmaceutical wastewater management, quantifying the organic pollutant load that must be removed before effluent can be safely discharged. Because pharmaceutical effluents contain solvents, intermediates and active ingredients at concentrations one to two orders of magnitude above domestic sewage, accurate COD evaluation directly drives treatment process design, operational control and regulatory compliance. This article explains the sample types, testing parameters, analytical methods and practical applications of COD assessment in the pharmaceutical industry.

Technical Overview

Chemical Oxygen Demand (COD) is the mass concentration of oxygen consumed when organic matter and oxidizable inorganic compounds in a water sample are chemically oxidized by a strong oxidizing agent under controlled acidic and heated conditions, expressed in milligrams per liter (mg/L). It is the most widely used aggregate indicator of organic pollution strength in industrial effluent and is designated as a primary compliance parameter in discharge permits across virtually all jurisdictions.

Pharmaceutical wastewater is among the most challenging industrial effluents to characterize. Depending on the manufacturing route, which may involve chemical synthesis, fermentation, natural product extraction, biological products, traditional medicine processing, or final formulation, the effluent can contain residual solvents such as methanol, ethanol, dichloromethane and toluene, reaction intermediates, active pharmaceutical ingredients (APIs), unreacted raw materials, and formulation excipients. COD concentrations in raw combined streams commonly range from 2,000 to over 30,000 mg/L, while concentrated mother liquors may exceed 100,000 mg/L. The ratio of five-day biochemical oxygen demand to COD (BOD5/COD) is frequently below 0.3, signaling refractory or biologically inhibitory organics.

Key analytical and treatment challenges specific to pharmaceutical effluent include:

• High chloride and sulfate salinity generated by acidification, salting-out and neutralization steps, which interferes with dichromate oxidation.
• Wide pH excursions and strong fluctuating pollutant loads caused by batch production campaigns.
• Biologically toxic substances, including antibiotics and cytotoxic compounds, that suppress conventional activated sludge systems.
• Color and turbidity that can bias spectrophotometric readings if not properly handled.

For these reasons, a rigorous COD assessment program combining representative sampling, interference-controlled analytical methods, and correlation with complementary parameters is essential. In China, results must be evaluated against the category-specific pharmaceutical discharge standards GB 21903-2008 through GB 21908-2008, and where applicable the integrated discharge standard GB 8978-1996.

Testing Samples

Raw (Untreated) Process Effluent

Composite or grab samples collected from production workshops, solvent recovery units, and equalization basins ahead of any treatment. These define the pollutant load entering the wastewater plant and form the basis of process sizing and COD mass-balance calculations. Because batch campaigns create large concentration swings, time- or flow-proportional composite sampling over a complete production cycle is recommended in accordance with HJ 91.1-2019.

Intermediate Treatment Streams

Samples taken after unit operations such as pH adjustment, iron-carbon micro-electrolysis, Fenton oxidation, coagulation and flotation, hydrolysis-acidification, and after each biological stage (anaerobic, anoxic, aerobic). Pairing COD values across successive units yields stage-by-stage removal efficiencies that reveal underperforming processes.

Treated Final Effluent

Representative samples collected at the plant outfall or monitoring manhole after clarification and disinfection. These determine compliance with permitted COD limits and, where online monitoring applies, are used to validate and calibrate continuous analyzers.

High-Chloride and High-Salinity Streams

Effluent fractions with chloride concentrations exceeding 1,000 mg/L, typical of synthesis routes using hydrochloric acid or brine workups. These samples require special preservation, reagent ratios, or the chlorine-correction determination described in the methods section.

All samples should be collected in clean glass containers, acidified to pH not greater than 2 with concentrated sulfuric acid, stored at approximately 4 degrees Celsius, and analyzed as soon as practicable, typically within 48 hours, following HJ 493-2009.

Testing Items

COD is the core determination, but a defensible assessment evaluates it alongside supporting parameters that explain variability and confirm treatability:

• Chemical oxygen demand (dichromate equivalent), the primary compliance metric.
• BOD5 and the BOD5/COD ratio, used to judge biodegradability and pretreatment needs.
• Total organic carbon (TOC), increasingly accepted as a correlated alternative indicator.
• pH, conductivity, and salinity, which affect both oxidation chemistry and biological treatment.
• Suspended solids and settleable solids, which influence total oxygen demand distribution.
• Ammonia nitrogen, total nitrogen and total phosphorus, key nutrients and regulated pollutants.
• Oils, phenols and residual volatile solvents characteristic of synthesis operations.
• Residual oxidants and, where relevant, antibacterial activity that may inhibit biodegradation.

Testing Methods

Dichromate Reflux Method (Reference Method)

The procedure specified in HJ 828-2017, which superseded GB 11914-89, is technically aligned with ISO 6060 and ASTM D1252. The sample is digested with a known excess of potassium dichromate in a strongly sulfuric acid medium with silver sulfate catalyst for two hours of open reflux (or an equivalent closed-tube digestion), after which the residual dichromate is titrated with standardized ferrous ammonium sulfate using ferroin indicator. Mercuric sulfate is added to complex chloride interference at concentrations up to about 1,000 mg/L. The method is most authoritative for undiluted samples in the approximate range of 10 to 700 mg/L, with dilution extending the upper range, and its results are typically preferred in compliance verification and dispute resolution.

Rapid Digestion Spectrophotometric Method

Described in HJ/T 399-2007 and comparable to colorimetric approaches such as US EPA Method 410.4, this technique digests the sample in a sealed reagent tube at 165 degrees Celsius for about 20 minutes, then determines the produced trivalent chromium or the residual hexavalent chromium photometrically at 440 or 600 nanometers. It offers low reagent consumption, high throughput and minimal operator exposure, making it the practical choice for routine process control, while certified reference materials and periodic cross-checks against the reflux method maintain traceability.

Chlorine-Correction Method for High-Chloride Samples

When chloride exceeds the masking capacity of mercuric sulfate, significant positive bias occurs because dichromate oxidizes chloride to chlorine. The chlorine-correction determination of HJ/T 70-2001 absorbs the evolved chlorine and quantifies it iodometrically so that its contribution can be subtracted, producing a corrected COD representative of the true organic load in saline pharmaceutical effluents.

Online Continuous COD Monitoring

Key dischargers commonly install continuous COD analyzers at outfalls in line with the HJ 353 to HJ 356 series covering installation, acceptance, operation and data validity of pollution-source online monitoring systems. Dichromate-based automatic analyzers provide direct regulatory data, while UV-254 surrogate sensors offer reagent-free operation but require site-specific calibration against laboratory dichromate results, with periodic verification of the correlation model.

Quality assurance across all methods should include reagent blanks, duplicate determinations with relative deviation limits, certified reference materials, matrix spike recoveries, and participation in interlaboratory comparisons, ideally within a quality management system conforming to ISO/IEC 17025 in accredited third-party laboratories.

Applications

COD assessment data underpin nearly every engineering and regulatory decision in pharmaceutical wastewater management:

• Treatment plant design and uprating, where daily COD mass load in kilograms defines the sizing of equalization tanks, anaerobic reactors such as UASB or IC units operated at organic loading rates of roughly 5 to 15 kg COD per cubic metre per day, and downstream aerobic SBR or MBR systems.
• Operational control, where upward trends in influent COD or sudden drops in removal efficiency identify shock loads, toxic inputs, or sludge bulking before permit violations occur.
• Regulatory compliance reporting, pollutant fee and environmental tax settlement, and discharge permit monitoring against GB 21903 through GB 21908 category limits.
• Cleaner production audits, in which COD mass balances across workshops locate solvent and mother-liquor recovery opportunities that reduce load at the source.
• Environmental impact assessment for new facilities, expansions, and production changeovers.
• Validation of advanced treatment technologies, including Fenton and ozone-based advanced oxidation, evaporation and mechanical vapor recompression, and the development of TOC-to-COD conversion factors accepted by permitting authorities.

FAQ

Q: Why is the COD of pharmaceutical wastewater so much higher than that of domestic sewage?

A: Pharmaceutical processes concentrate organic reactants, intermediates and solvents at production strength, and losses to wash water and mother liquors carry a heavy organic load. Raw combined effluent commonly reaches 2,000 to 30,000 mg/L, roughly ten times typical municipal sewage, and concentrated side streams can exceed 100,000 mg/L.

Q: What does the BOD5/COD ratio indicate?

A: A ratio above 0.5 indicates good biodegradability suitable for direct biological treatment; 0.3 to 0.5 indicates moderate biodegradability; below 0.3 the wastewater is largely refractory and typically requires pretreatment such as hydrolysis-acidification, iron-carbon micro-electrolysis, Fenton oxidation, or electrochemical oxidation before biological polishing.

Q: How is chloride interference handled?

A: Mercuric sulfate is added in the standard dichromate method to complex chloride at levels up to about 1,000 mg/L. For higher salinity, samples are diluted where possible, or analyzed using the chlorine-correction method of HJ/T 70-2001, which subtracts the oxygen demand attributable to chloride oxidation.

Q: What COD discharge limits apply to pharmaceutical manufacturers?

A: In China, the category standards GB 21903-2008 through GB 21908-2008 assign limits according to the production process, with direct discharge limits commonly in the range of about 50 to 120 mg/L, higher negotiated limits for indirect discharge to municipal plants, and stricter special emission limits in sensitive receiving-water regions. The applicable local regulation should always be confirmed.

Q: How frequently should COD be monitored?

A: Final effluent is generally monitored daily or per shift under the discharge permit, major dischargers operate approved online analyzers continuously, and raw and intermediate streams are sampled according to the production campaign plan to capture batch-to-batch variability.

Q: Can TOC replace COD measurements?

A: TOC is faster and reagent-free, and many authorities accept it as a controlled alternative when a documented, statistically validated site-specific TOC-to-COD correlation is established and periodically reverified against the reference dichromate method.